Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study

BACKGROUND: Emerging data in chronic kidney disease (CKD) patients suggest that iron deficiency and higher circulating levels of erythropoietin (EPO) stimulate the expression and concomitant cleavage of the osteocyte-derived, phosphate-regulating hormone fibroblast growth factor 23 (FGF23), a risk f...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS Med
Egile Nagusiak: Eisenga, Michele F., De Jong, Maarten A., Van der Meer, Peter, Leaf, David E., Huls, Gerwin, Nolte, Ilja M., Gaillard, Carlo A. J. M., Bakker, Stephan J. L., De Borst, Martin H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6553711/
https://ncbi.nlm.nih.gov/pubmed/31170159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.1002818
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak